The applications of biomarkers in early clinical drug development to improve decision-making processes.

Kuhlmann, J

Kuhlmann, J.

Affiliation

Kuhlmann J; Bayer Health Care AG, Pharma Center, Wuppertal, Germany. jochen.kuhlmann@bayerhealthcare.com

Ernst Schering Res Found Workshop ; (59): 29-45, 2007.

Article in En | MEDLINE | ID: mdl-17117713

Subject(s)

Biomarkers/chemistry; Chemistry, Pharmaceutical/methods; Drug Industry/methods; Animals; Cardiovascular Diseases/diagnosis; Central Nervous System/pathology; Decision Making; Drug Design; Drug Evaluation, Preclinical; Drug Industry/legislation & jurisprudence; Humans; Pharmacogenetics; United States; United States Food and Drug Administration

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Chemistry, Pharmaceutical / Drug Industry Type of study: Diagnostic_studies / Prognostic_studies Limits: Animals / Humans Country/Region as subject: America do norte Language: En Journal: Ernst Schering Res Found Workshop Year: 2007 Document type: Article

Search on Google

XML

PubMed Links